Agios Reports Second Quarter 2026 Financial Results and Provides Business Update CAMBRIDGE, Mass., July 30, 2026 – Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial- stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced financial results and updates for the second quarter ended June 30, 2026. "Our second-quarter performance reflects continued execution across the key priorities that will drive sustainable growth for Agios: strong c ...